Shedding light on photophobia

Journal of Neuro-Ophthalmology

Volumn 32, Issue 1, 2012, Pages 68-81

  Digre, Kathleen B ^a   Brennan, K C ^a  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALCOHOL; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFLAMMATORY AGENT; ANXIOLYTIC AGENT; BACLOFEN; BARBITURIC ACID DERIVATIVE; BENZODIAZEPINE; BENZODIAZEPINE DERIVATIVE; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN; CALCIUM CHANNEL BLOCKING AGENT; CARBAMAZEPINE; CARBIDOPA PLUS LEVODOPA; CYCLOPLEGIC AGENT; FLUOXETINE; GABAPENTIN; HARKOSERIDE; LIDOCAINE; MELATONIN; ORPHENADRINE; PREGABALIN; SEDATIVE AGENT; TRICYCLIC ANTIDEPRESSANT AGENT;

ANTERIOR EYE SEGMENT; BLEPHAROSPASM; BRAIN DISEASE; CLINICAL FEATURE; DEPRESSION; DISEASE ASSOCIATION; DRY EYE; EYE DISEASE; HUMAN; MENTAL DISEASE; MIGRAINE; NEUROLOGIC DISEASE; NEUROOPHTHALMOLOGY; NOMENCLATURE; PHOTOPHOBIA; POSTERIOR EYE SEGMENT; PRIORITY JOURNAL; PROGRESSIVE SUPRANUCLEAR PALSY; REVIEW; SPECTACLES; SYMPATHETIC BLOCKING; SYMPTOMATOLOGY; TRAUMATIC BRAIN INJURY;

BLEPHAROSPASM; BRAIN INJURIES; EYE DISEASES; HUMANS; MIGRAINE DISORDERS; PHOTOPHOBIA; VISUAL PATHWAYS;

EID: 84857865921     PISSN: 10708022     EISSN: 15365166     Source Type: Journal    
DOI: 10.1097/WNO.0b013e3182474548     Document Type: Review

References (145)

1. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Headache Classification Committee of the International Headache Society. Cephalalgia. 1988;8(suppl 7):1-96.
2. Headache Classification Committee of the International Headache Society. The International Classification of Headache Disorders. Cephalalgia. 2004;24:1-160.
3. Trobe JD. Photophobia in anterior visual pathway disease. J Neuroophthalmol. 2002;22:1-2.
4. Webster's New World Dictionary. Cleveland, OH: The World Publishing Company, 1968.
5. Lebensohn J. The nature of photophobia. Arch Ophthalmol. 1934;12:380-383.
6. Cummings JL, Gittinger JW Jr. Central dazzle. A thalamic syndrome? Arch Neurol. 1981;38:372-374.
7. Loewenfeld I. The "dazzling" syndrome. In: The Pupil: Anatomy, Physiology, and Clinical Applications. Detroit, MI: Wayne State University Press, 1993:1200.
8. Ohba N, Ohba A. Nyctalopia and hemeralopia: The current usage trend in the literature. Br J Ophthalmol. 2006;90:1548-1549.
9. Fine PG, Digre KB. A controlled trial of regional sympatholysis in the treatment of photo-oculodynia syndrome. J Neuroophthalmol. 1995;15:90-94.
10. Burstein R, Cutrer MF, Yarnitsky D. The development of cutaneous allodynia during a migraine attack: Clinical evidence for the sequential recruitment of spinal and supraspinal nociceptive neurons in migraine. Brain. 2000;123(pt 8):1703-1709.
11. Mathew NT, Kailasam J, Seifert T. Clinical recognition of allodynia in migraine. Neurology. 2004;63:848-852.
12. Buchanan T, Digre K, Warner JE, Katz BJ. A review of the symptom of photophobia in an eye clinic. Neurology. 2009;72:A184.
13. Pflugfelder SC. Tear dysfunction and the cornea: LXVIII Edward Jackson Memorial Lecture. Am J Ophthalmol. 2011;152:900-909 e901.
14. Benitez-Del-Castillo JM, Acosta MC, Wassfi MA, Diaz-Valle D, Gegundez JA, Fernandez C, Garcia-Sanchez J. Relation between corneal innervation with confocal microscopy and corneal sensitivity with noncontact esthesiometry in patients with dry eye. Invest Ophthalmol Vis Sci. 2007;48:173-181.
15. Karmel M. Addressing the pain of corneal neuropathy [online]. Available at: Http://www.aao.org/publications/ eyenet/201007/upload/29-CUcornea-FF-copy. pdf. Accessed November 18, 2011.
16. Prokofyeva E, Troeger E, Wilke R, Zrenner E. Early visual symptom patterns in inherited retinal dystrophies. Ophthalmologica. 2011;226:151-156.
17. Zervas JP, Smith JL. Neuro-ophthalmic presentation of cone dysfunction syndromes in the adult. J Clin Neuroophthalmol. 1987;7:202-218.
18. Simunovic MP, Moore AT. The cone dystrophies. Eye (Lond). 1998;12(pt 3b):553-565.
19. Russell-Eggitt IM, Clayton PT, Coffey R, Kriss A, Taylor DS, Taylor JF. Alstrom syndrome. Report of 22 cases and literature review. Ophthalmology. 1998;105:1274-1280.
20. Lamonte M, Silberstein SD, Marcelis JF. Headache associated with aseptic meningitis. Headache. 1995;35:520-526.
21. Welty TE, Horner TG. Pathophysiology and treatment of subarachnoid hemorrhage. Clin Pharm. 1990;9:35-39.
22. Kawasaki A, Purvin VA. Photophobia as the presenting visual symptom of chiasmal compression. J Neuroophthalmol. 2002;22:3-8.
23. Fricke B, Andres KH, Von During M. Nerve fibers innervating the cranial and spinal meninges: Morphology of nerve fiber terminals and their structural integration. Microsc Res Tech. 2001;53:96-105.
24. Choi JY, Oh K, Kim BJ, Chung CS, Koh SB, Park KW. Usefulness of a photophobia questionnaire in patients with migraine. Cephalalgia. 2009;29:953-959.
25. Lipton RB, Dodick D, Sadovsky R, Kolodner K, Endicott J, Hettiarachchi J, Harrison W. A self-administered screener for migraine in primary care: The ID Migraine validation study. Neurology. 2003;61:375-382.
26. Drummond PD, Woodhouse A. Painful stimulation of the forehead increases photophobia in migraine sufferers. Cephalalgia. 1993;13:321-324.
27. Vanagaite J, Pareja JA, Storen O, White LR, Sand T, Stovner LJ. Light-induced discomfort and pain in migraine. Cephalalgia. 1997;17:733-741.
28. Vincent AJ, Spierings EL, Messinger HB. A controlled study of visual symptoms and eye strain factors in chronic headache. Headache. 1989;29:523-527.
29. Good PA, Taylor RH, Mortimer MJ. The use of tinted glasses in childhood migraine. Headache. 1991;31:533-536.
30. Chronicle EP, Mulleners WM. Visual system dysfunction in migraine: A review of clinical and psychophysical findings. Cephalalgia. 1996;16:525-535; discussion 523.
31. Drummond PD. A quantitative assessment of photophobia in migraine and tension headache. Headache. 1986;26:465-469.
32. Irimia P, Cittadini E, Paemeleire K, Cohen AS, Goadsby PJ. Unilateral photophobia or phonophobia in migraine compared with trigeminal autonomic cephalalgias. Cephalalgia. 2008;28:626-630.
33. Cittadini E, Goadsby PJ. Hemicrania continua: A clinical study of 39 patients with diagnostic implications. Brain. 2010;133:1973-1986.
34. Waddell PA, Gronwall DM. Sensitivity to light and sound following minor head injury. Acta Neurol Scand. 1984;69:270-276.
35. Vos PE, Battistin L, Birbamer G, Gerstenbrand F, Potapov A, Prevec T, Stepan ChA, Traubner P, Twijnstra A, Vecsei L, von Wild K. EFNS guideline on mild traumatic brain injury: Report of an EFNS task force. Eur J Neurol. 2002;9:207-219.
36. Bohnen N, Twijnstra A, Wijnen G, Jolles J. Tolerance for light and sound of patients with persistent post-concussional symptoms 6 months after mild head injury. J Neurol. 1991;238:443-446.
37. Nampiaparampil DE. Prevalence of chronic pain after traumatic brain injury: A systematic review. JAMA. 2008;300:711-719.
38. Hoge CW, McGurk D, Thomas JL, Cox AL, Engel CC, Castro CA. Mild traumatic brain injury in U.S. Soldiers returning from Iraq. N Engl J Med. 2008;358:453-463.
39. Ruff RL, Ruff SS, Wang XF. Headaches among Operation Iraqi Freedom/Operation Enduring Freedom veterans with mild traumatic brain injury associated with exposures to explosions. J Rehabil Res Dev. 2008;45:941-952.
40. Neely ET, Midgette LA, Scher AI. Clinical review and epidemiology of headache disorders in US service members: With emphasis on post-traumatic headache. Headache. 2009;49:1089-1096.
41. Berardelli A, Rothwell JC, Day BL, Marsden CD. Pathophysiology of blepharospasm and oromandibular dystonia. Brain. 1985;108(pt 3):593-608.
42. Anderson RL, Patel BC, Holds JB, Jordan DR. Blepharospasm: Past, present, and future. Ophthal Plast Reconstr Surg. 1998;14:305-317.
43. Judd R, Digre KB, Warner JE, Schulman S, Katz BJ. Shedding light on blepharospasm: A patient-researcher partnership approach to assessment of photophobia and impact on activities of daily living. Neuroophthalmology. 2007;31:49-54.
44. Adams WH, Digre KB, Patel BC, Anderson RL, Warner JE, Katz BJ. The evaluation of light sensitivity in benign essential blepharospasm. Am J Ophthalmol. 2006;142:82-87.
45. Cooper AD, Josephs KA. Photophobia, visual hallucinations, and REM sleep behavior disorder in progressive supranuclear palsy and corticobasal degeneration: A prospective study. Parkinsonism Relat Disord. 2009;15:59-61.
46. Hills W, Warner JE, Katz BJ, Chelune G, Foster N, Steffens J, Thulin P, Chin S, Digre K. Neuro-Ophthalmic Findings That May Reliably Differentiate Progressive Supranuclear Palsy and Parkinson's Disease. Chicago, IL: American Academy of Neurology, 2008.
47. Kellner M, Wiedemann K, Zihl J. Illumination perception in photophobic patients suffering from panic disorder with agoraphobia. Acta Psychiatr Scand. 1997;96:72-74.
48. Shirani A, St Louis EK. Illuminating rationale and uses for light therapy. J Clin Sleep Med. 2009;5:155-163.
49. Gerbaldo H. Depression and photophobic behavior. Am J Psychiatry. 1988;145:1479-1480.
50. Gerbaldo H, Thaker G. Photophilic and photophobic behaviour in patients with schizophrenia and depression. Can J Psychiatry. 1991;36:677-679.
51. Gallin PF, Terman M, Reme CE, Rafferty B, Terman JS, Burde RM. Ophthalmologic examination of patients with seasonal affective disorder, before and after bright light therapy. Am J Ophthalmol. 1995;119:202-210.
52. Bossini L, Fagiolini A, Valdagno M, Padula L, Hofkens T, Castrogiovanni P. Photosensitivity in panic disorder. Depress Anxiety. 2009;26:E34-E36.
53. Bengtzen R, Woodward M, Lynn MJ, Newman NJ, Biousse V. The "sunglasses sign" predicts nonorganic visual loss in neuro-ophthalmologic practice. Neurology. 2008;70:218-221.
54. Schutz JS, Mavrakanas NA. The value of the ophthalmological independent medical examination: Analysis of 344 cases. Br J Ophthalmol. 2009;93:1371-1375.
55. Weller M, Wiedemann P. Hysterical symptoms in ophthalmology. Doc Ophthalmol. 1989;73:1-33.
56. Burton H. Somatic sensation from the eye. In: Hart WM, ed. Adler's Physiology of the Eye. St Louis, MO: Mosby Year Book, 1992:71-100.
57. Last R. Eugene Wolff's Anatomy of the Eye and Orbit, 5th edition. Philadelphia, PA: W.B. Saunders, 1961.
58. Edvinsson L, Uddman R. Neurobiology in primary headaches. Brain Res Brain Res Rev. 2005;48:438-456.
59. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neurobiology of migraine. Neuroscience. 2009;161:327-341.
60. Goadsby PJ. Pathophysiology of migraine. Neurol Clin. 2009;27:335-360.
61. Akerman S, Holland PR, Goadsby PJ. Diencephalic and brainstem mechanisms in migraine. Nat Rev Neurosci. 2011;12:570-584.
62. Marfurt CF. Sympathetic innervation of the rat cornea as demonstrated by the retrograde and anterograde transport of horseradish peroxidase-wheat germ agglutinin. J Comp Neurol. 1988;268:147-160.
63. Davis L, Pollock L. The rôle of the sympathetic nervous system in the production of pain in the head. Arch Neurol Psychiatry. 1932;27:282-293.
64. McCann JD, Gauthier M, Morschbacher R, Goldberg RA, Anderson RL, Fine PG, Digre KB. A novel mechanism for benign essential blepharospasm. Ophthal Plast Reconstr Surg. 1999;15:384-389.
65. Esteban A. A neurophysiological approach to brainstem reflexes. Blink reflex. Neurophysiol Clin. 1999;29:7-38.
66. Yates SK, Brown WF. Light-stimulus-evoked blink reflex: Methods, normal values, relation to other blink reflexes, and observations in multiple sclerosis. Neurology. 1981;31:272-281.
67. Bologna M, Agostino R, Gregori B, Belvisi D, Ottaviani D, Colosimo C, Fabbrini G, Berardelli A. Voluntary, spontaneous and reflex blinking in patients with clinically probable progressive supranuclear palsy. Brain. 2009;132:502-510.
68. Pearce JM. Observations on the blink reflex. Eur Neurol. 2008;59:221-223.
69. Aramideh M, Ongerboer de Visser BW. Brainstem reflexes: Electrodiagnostic techniques, physiology, normative data, and clinical applications. Muscle Nerve. 2002;26:14-30.
70. Blackburn MK, Lamb RD, Digre KB, Smith AG, Warner JE, McClane RW, Nandedkar SD, Langeberg WJ, Holubkov R, Katz BJ. FL-41 tint improves blink frequency, light sensitivity, and functional limitations in patients with benign essential blepharospasm. Ophthalmology. 2009;116:997-1001.
71. Siegwart K. Zur Frage nach dem Vorkommen and dem Wesen des Blednungsschmerzes. Schweizmed Wchschr. 1920;50:1165.
72. Zaidi FH, Hull JT, Peirson SN, Wulff K, Aeschbach D, Gosley JJ, Brainard GS, Gregory-Evans K, Rizzo J, Czeisler CA, Foster RG, Lockley SW. Short-wavelength light sensitivity of circadian, pupillary, and visual awareness in humans lacking an outer retina. Curr Biol. 2007;17:2122-2128.
73. Noseda R, Burstein R. Advances in understanding the mechanisms of migraine-type photophobia. Curr Opin Neurol. 2011;24:197-202.
74. Amini A, Digre K, Couldwell WT. Photophobia in a blind patient: An alternate visual pathway. Case report. J Neurosurg. 2006;105:765-768.
75. Guler AD, Ecker JL, Lall GS, Haq S, Altimus CM, Lido HW, Barnard AR, Cahill H, Badea TC, Zhao H, Hankins MW, Berson DM, Lucas RJ, Yau KW, Haltar S. Melanopsin cells are the principal conduits for rod-cone input to non-image-forming vision. Nature. 2008;453:102-105.
76. Wilhelm H. The pupil. Curr Opin Neurol. 2008;21:36-42.
77. Kardon R, Anderson SC, Damarjian TG, Grace EM, Stone E, Kawasaki A. Chromatic pupil responses: Preferential activation of the melanopsin-mediated versus outer photoreceptor-mediated pupil light reflex. Ophthalmology. 2009;116:1564-1573.
78. Kawasaki A, Kardon RH. Intrinsically photosensitive retinal ganglion cells. J Neuroophthalmol. 2007;27:195-204.
79. Berson DM, Dunn FA, Takao M. Phototransduction by retinal ganglion cells that set the circadian clock. Science. 2002;295:1070-1073.
80. Hattar S, Liao HW, Takao M, Berson DM, Yau KW. Melanopsin-containing retinal ganglion cells: Architecture, projections, and intrinsic photosensitivity. Science. 2002;295:1065-1070.
81. Do MT, Yau KW. Intrinsically photosensitive retinal ganglion cells. Physiol Rev. 2010;90:1547-1581.
82. Chen SK, Badea TC, Hattar S. Photoentrainment and pupillary light reflex are mediated by distinct populations of ipRGCs. Nature. 2011;476:92-95.
83. Schmidt TM, Chen SK, Hattar S. Intrinsically photosensitive retinal ganglion cells: Many subtypes, diverse functions. Trends Neurosci. 2011;34:572-580.
84. Xue T, Do MT, Riccio A, Jiang Z, Hsieh J, Wang HC, Merbs SL, Welsbie DS, Yoshioka T, Weissgerber P, Stolz S, Flockerzi V, Friechel M, Simon MI, Clapham DE, Yau KW. Melanopsin signalling in mammalian iris and retina. Nature. 2011;479:67-73.
85. Okamoto K, Thompson R, Tashiro A, Chang Z, Bereiter DA. Bright light produces Fos-positive neurons in caudal trigeminal brainstem. Neuroscience. 2009;160: 858-864.
86. Noseda R, Constandil L, Bourgeais L, Chalus M, Villanueva L. Changes of meningeal excitability mediated by corticotrigeminal networks: A link for the endogenous modulation of migraine pain. J Neurosci. 2010;30:14420-14429.
87. Hirata A, Aguilar J, Castro-Alamancos MA. Noradrenergic activation amplifies bottom-up and top-down signal-to-noise ratios in sensory thalamus. J Neurosci. 2006;26:4426-4436.
88. Llinas RR, Steriade M. Bursting of thalamic neurons and states of vigilance. J Neurophysiol. 2006;95:3297-3308.
89. Steriade M, McCormick DA, Sejnowski TJ. Thalamocortical oscillations in the sleeping and aroused brain. Science. 1993;262:679-685.
90. Nicolelis MA, Fanselow EE. Thalamocortical [correction of thalamcortical] optimization of tactile processing according to behavioral state. Nat Neurosci. 2002;5:517-523.
91. Dolgonos S, Ayyala H, Evinger C. Light-induced trigeminal sensitization without central visual pathways: Another mechanism for photophobia. Invest Ophthalmol Vis Sci. 2011;52:7852-7858.
92. Custer PL, Reistad CE. Enucleation of blind, painful eyes. Ophthal Plast Reconstr Surg. 2000;16:326-329.
93. Olesen J, Diener HC, Husstedt IW, Goadsby PJ, Hall D, Meier U, Pollentier S, Lesko LM. Calcitonin gene-related peptide receptor antagonist BIBN 4096 BS for the acute treatment of migraine. N Engl J Med. 2004;350:1104-1110.
94. Ho TW, Ferrari MD, Dodick DW, Galet V, Kost J, Fan X, Leibensperger H, Froman S, Assaid C, Lines C, Koppen H, Winner PK. Efficacy and tolerability of MK-0974 (telcagepant), a new oral antagonist of calcitonin gene-related peptide receptor, compared with zolmitriptan for acute migraine: A randomised, placebo-controlled, parallel-treatment trial. Lancet. 2008;372:2115-2123.
95. Russo AF, Kuburas A, Kaiser EA, Raddant AC, Recober A. A potential preclinical migraine model: CGRP-sensitized mice. Mol Cell Pharmacol. 2009;1:264-270.
96. Sprenger T, Goadsby PJ. Migraine pathogenesis and state of pharmacological treatment options. BMC Med. 2009;7:71.
97. Recober A, Kaiser EA, Kuburas A, Russo AF. Induction of multiple photophobic behaviors in a transgenic mouse sensitized to CGRP. Neuropharmacology. 2010;58:156-165.
98. Recober A, Kuburas A, Zhang Z, Wemmie JA, Anderson MG, Russo AF. Role of calcitonin gene-related peptide in lightaversive behavior: Implications for migraine. J Neurosci. 2009;29:8798-8804.
99. Vanagaite Vingen J, Stovner LJ. Photophobia and phonophobia in tension-type and cervicogenic headache. Cephalalgia. 1998;18:313-318.
100. Wirtschafter JD, Bourassa CM, Dow RS. The quantitative study of photophobia. Trans Am Neurol Assoc. 1963;88:291-293.
101. Marks L. Brightness and equivalent intensity of intrinsic light. Vision Res. 1973;13:371-382.
102. Lamb TD, Pugh EN Jr. Dark adaptation and the retinoid cycle of vision. Prog Retin Eye Res. 2004;23:307-380.
103. Main A, Vlachonikolis I, Dowson A. The wavelength of light causing photophobia in migraine and tension-type headache between attacks. Headache. 2000;40:194-199.
104. Brainard GC, Sliney D, Hanifin JP, Glickman G, Byrne B, Greeson JM, Jassen S, Gerna E, Rollag MD. Sensitivity of the human circadian system to short-wavelength (420-nm) light. J Biol Rhythms. 2008;23:379-386.
105. Kowacs PA, Piovesan EJ, Werneck LC, Tatsui CE, Lange MC, Ribas LC, da Silva HP. Influence of intense light stimulation on trigeminal and cervical pain perception thresholds. Cephalalgia. 2001;21:184-188.
106. Moulton EA, Becerra L, Borsook D. An fMRI case report of photophobia: Activation of the trigeminal nociceptive pathway. Pain. 2009;145:358-363.
107. Legrain V, Iannetti GD, Plaghki L, Mouraux A. The pain matrix reloaded: A salience detection system for the body. Prog Neurobiol. 2011;93:111-124.
108. Malecaze FJ, Boulanouar KA, Demonet JF, Guell JL, Imbert MA. Abnormal activation in the visual cortex after corneal refractive surgery for myopia: Demonstration by functional magnetic resonance imaging. Ophthalmology. 2001;108:2213-2218.
109. Emoto H, Suzuki Y, Wakakura M, Horie C, Kiyosawa M, Mochizuki M, Kawasaki K, Oda K, Ishiwata K, Ishii K. Photophobia in essential blepharospasm-a positron emission tomographic study. Mov Disord. 2010;25:433-439.
110. Coppola G, Pierelli F, Schoenen J. Is the cerebral cortex hyperexcitable or hyperresponsive in migraine? Cephalalgia. 2007;27:1427-1439.
111. Olesen J, Larsen B, Lauritzen M. Focal hyperemia followed by spreading oligemia and impaired activation of rCBF in classic migraine. Ann Neurol. 1981;9:344-352.
112. Hadjikhani N, Sanchez Del Rio M, Wu O, Schwartz D, Bakker D, Fischi B, Kwang KK, Cotren FM, Rosen BR, Tootell RB, Sorensen AG, Moskowitz MA. Mechanisms of migraine aura revealed by functional MRI in human visual cortex. Proc Natl Acad Sci U S A. 2001;98:4687-4692.
113. Denuelle M, Boulloche N, Payoux P, Fabre N, Trotter Y, Geraud G. A PET study of photophobia during spontaneous migraine attacks. Neurology. 2011;76:213-218.
114. Boulloche N, Denuelle M, Payoux P, Fabre N, Trotter Y, Geraud G. Photophobia in migraine: An interictal PET study of cortical hyperexcitability and its modulation by pain. J Neurol Neurosurg Psychiatry. 2010;81:978-984.
115. Brennan KC. Turn down the lights! An irritable occipital cortex in migraine without aura. Neurology. 2011;76:206-207.
116. Martin H, Del Rio MS, de Silanes CL, Alvarez-Linera J, Hernandez JA, Pareja JA. Photoreactivity of the occipital cortex measured by functional magnetic resonance imagingblood oxygenation level dependent in migraine patients and healthy volunteers: Pathophysiological implications. Headache. 2011;51:1520-1528.
117. Llop S, Frandsen F, Katz BJ, Warner JE, Digre K. Depression and anxiety in migraine patients with and without chronic photophobia. Headache. 2010;50:S45.
118. Bruce BB, Newman NJ. Functional visual loss. Neurol Clin. 2010;28:789-802.
119. Howard RJ, Valori RM. Hospital patients who wear tinted spectacles-physical sign of psychoneurosis: A controlled study. J R Soc Med. 1989;82:606-608.
120. Marshall JD, Paisey RB, Carey C, Macdermott S. Alstrom syndrome. In: Pagon RA, Bird TD, Dolan CR, Stephens K, eds. GeneReviews [Internet]. Seattle, WA: University of Washington, 1993-2003; [updated June 08, 2010].
121. Rajak SN, Currie AD, Dubois VJ, Morris M, Vickers S. Tinted contact lenses as an alternative management for photophobia in stationary cone dystrophies in children. J AAPOS. 2006;10:336-339.
122. Michaelides M, Hunt DM, Moore AT. The cone dysfunction syndromes. Br J Ophthalmol. 2004;88:291-297.
123. Young RS, Krefman RA, Fishman GA. Visual improvements with red-tinted glasses in a patient with cone dystrophy. Arch Ophthalmol. 1982;100:268-271.
124. Park WL, Sunness JS. Red contact lenses for alleviation of photophobia in patients with cone disorders. Am J Ophthalmol. 2004;137:774-775.
125. Karanovic O, Thabet M, Wilson HR, Wilkinson F. Detection and discrimination of flicker contrast in migraine. Cephalalgia. 2011;31:723-736.
126. Huang J, Zong X, Wilkins A, Jenkins B, Bozoki A, Cao Y. fMRI evidence that precision ophthalmic tints reduce cortical hyperactivation in migraine. Cephalalgia. 2011;31:925-936.
127. Hallett M, Evinger C, Jankovic J, Stacy M. Update on blepharospasm: Report from the BEBRF International Workshop. Neurology. 2008;71:1275-1282.
128. McDonald MB, Wyse TB, Borodkin MJ, Ocmand A, Shoelson B, Thompson H. Comparison of the effectiveness of 4 anti-inflammatory drops in relieving photophobia after pupil dilation. J Cataract Refract Surg. 1999;25:405-410.
129. Brierley L. Effect of lidocaine on photophobia. J Cataract Refract Surg. 1999;25:1177.
130. Lebensohn JE. Photophobia: Mechanism and implications. Am J Ophthalmol. 1951;34:1294-1300.
131. Spencer BR Jr, Digre KB. Treatments for neuro-ophthalmologic conditions. Neurol Clin. 2010;28:1005-1035.
132. Hoyt W. Walsh and Hoyt's Neuro-Ophthalmology, 3rd edition. Philadelphia, PA: Lippincott Williams and Wilkins, 1969.
133. Freeman MD, Nystrom A, Centeno C. Chronic whiplash and central sensitization; an evaluation of the role of a myofascial trigger points in pain modulation. J Brachial Plex Peripher Nerve Inj. 2009;4:2.
134. Shoari M, Katz BJ. Treatment of the photo-oculodynia syndrome with botulinum toxin A. Neuro-Ophthalmology. 2007;31:105-110.
135. Diener HC, Dodick DW, Aurora SK, Turkell CC, DeGryse RE, Lipton RB, Silberstein SD, Brin MF. OnabotulinumtoxinA for treatment of chronic migraine: Results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia. 2010;30:804-814.
136. Magitot A. Photophobie. Ann D'ocul. 1937;174:917.
137. Tugal-Tutkun I, Araz B, Taskapili M, Akora YA, Yalniz-Alkkaya Z, Berkeu N, Emie S, Gezer A. Bilateral acute depigmentation of the iris: Report of 26 new cases and four-year follow-up of two patients. Ophthalmology. 2009;116:1552-1557, 1557 e1551.
138. Soeters MR, van Zeijl CJ, Boelen A, Kloos R, Saeed P, Vriesendrop TM, Mourits MP. Optimal management of Graves orbitopathy: A multidisciplinary approach. Neth J Med. 2011;69:302-308.
139. Enkvetchakul O, Thanathanee O, Rangsin R, Lekhanont K, Suwan-Apichon O. A randomized controlled trial of intralesional bevacizumab injection on primary pterygium: Preliminary results. Cornea. 2011;30: 1213-1218.
140. van der Veen RL, Fuijkschot J, Willemsen MA, Cruysberg JR, Berendschot TT, Theelen T. Patients with Sjogren-Larsson syndrome lack macular pigment. Ophthalmology. 2010;117:966-971.
141. Kaur H, Uy C, Kelly J, Moses AM. Orbital inflammatory disease in a patient treated with zoledronate. Endocr Pract. 2011;17:e101-e103.
142. Alshami M, Bawazir MA, Atwan AA. Photoletter to the editor: A new variant of ichthyosis follicularis with alopecia and photophobia (IFAP) syndrome with coexisting psoriasiform lesions and palmoplantar keratoderma. IFAP-PPK syndrome? J Dermatol Case Rep. 2011;5:14-16.
143. Megarbane H, Megarbane A. Ichthyosis follicularis, alopecia, and photophobia (IFAP) syndrome. Orphanet J Rare Dis. 2011;6:29.
144. Carey J. Trisomy 18 and trisomy 13 syndromes. In: Cassidy S, Allanson J, eds. Management of Genetic Syndromes, 3rd edition. Hoboken, NJ: Wiley-Blackwell, 2010:807-825.
145. Yu HH, Yang TM, Shan YS, Lin PW. Zinc deficiency in patients undergoing pancreatoduodenectomy for periampullary tumors is associated with pancreatic exocrine insufficiency. World J Surg. 2011;35:2110-2117.